ImmunOs Therapeutics’ CHF 71 Million Series B Financing Round

Federica Tiefenthaler
Tagged:

Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv.ImmunOs Therapeutics AG, a…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

This content is for Standard 1 Year members only.
Login Join Now